RESEARCH STUDY
Research Study of a New Drug to Treat NASH
People ages 18 to 65 can help improve the lives of patients who suffer from Nonalcoholic Steatohepatitis (NASH). This study aims to determine the effectiveness of a new investigational medication in participants suffering from Nonalcoholic Steatohepatitis (NASH). The study will also investigate the safety and efficacy of the drug.
RESEARCH STUDY
Research Study of a New Drug to Treat NASH
People ages 18 to 65 can help improve the lives of patients who suffer from Nonalcoholic Steatohepatitis (NASH). This study aims to determine the effectiveness of a new investigational medication in participants suffering from Nonalcoholic Steatohepatitis (NASH). The study will also investigate the safety and efficacy of the drug.
RESEARCH STUDY
Research Study of a New Drug to Treat NASH
People ages 18 to 65 can help improve the lives of patients who suffer from Nonalcoholic Steatohepatitis (NASH). This study aims to determine the effectiveness of a new investigational medication in participants suffering from Nonalcoholic Steatohepatitis (NASH). The study will also investigate the safety and efficacy of the drug.
Participants Receive
Study participants receive study-related medical exams and the study drug at no cost.
Compensation for time and travel may be available.
About Nonalcoholic Steatohepatitis (NASH)
Nonalcoholic Steatohepatitis (NASH) is a progressive liver disease characterized by inflammation and fat buildup in the liver, which can lead to scarring (fibrosis) and severe complications, including cirrhosis and liver failure. It is a significant global health challenge, and advancing treatment options is critical to improving outcomes for those affected.
About Elixia and Our NASH Research Studies
At Elixia, we are committed to advancing medical research and improving lives through cutting-edge clinical studies. Our mission is to develop innovative solutions for chronic health conditions, including Nonalcoholic Steatohepatitis (NASH), by collaborating with individuals who share our vision for a healthier future.
You May Qualify If:
You are between the ages of 18-65 years old.
You have been diagnosed with NASH or a related liver condition.
You want to participate in a clinical study to improve the quality of care and life for future patients suffering from NASH.
Join the Study and Help Others Living with NASH. To see if you are eligible, please complete the form to get in touch with the study team.
Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.